{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:49:48Z","timestamp":1787021388320,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T00:00:00Z","timestamp":1364515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1245\/s10434-013-2955-0","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T13:56:40Z","timestamp":1364479000000},"page":"2842-2849","source":"Crossref","is-referenced-by-count":55,"title":["Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers"],"prefix":"10.1245","volume":"20","author":[{"given":"S. Shafaq","family":"Mujtaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Bi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Y. S.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu-Ki","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rin","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay-Hoon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,29]]},"reference":[{"issue":"1","key":"2955_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01806233","volume":"3","author":"ER Fisher","year":"1983","unstructured":"Fisher ER, Palekar AS, Sass R, Fisher B. Scar cancers: pathologic findings from the national surgical adjuvant breast project (protocol no. 4): IX. Breast Cancer Res Treat. 1983;3(1):39\u201359.","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"2955_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1440-1827.2000.01035.x","volume":"50","author":"T Hasebe","year":"2000","unstructured":"Hasebe T, Mukai K, Tsuda H, Ochiai A. New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus. Pathol Int. 2000;50(4):263\u201372.","journal-title":"Pathol Int."},{"issue":"4","key":"2955_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1349-7006.1996.tb00234.x","volume":"87","author":"T Hasebe","year":"1996","unstructured":"Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in invasive ductal carcinoma: an indicator of high tumor aggressiveness. Jpn J Cancer Res. 1996;87(4):385\u201394.","journal-title":"Jpn J Cancer Res."},{"issue":"5","key":"2955_CR4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.3880555","volume":"15","author":"T Hasebe","year":"2002","unstructured":"Hasebe T, Sasaki S, Imoto S, Mukai K, Yokose T, Ochiai A. Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study. Mod Pathol. 2002;15(5):502\u201316.","journal-title":"Mod Pathol."},{"issue":"3","key":"2955_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1006067513634","volume":"49","author":"T Hasebe","year":"1998","unstructured":"Hasebe T, Tsuda H, Hirohashi S, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients. Breast Cancer Res Treat. 1998;49(3):195\u2013208.","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"2955_CR6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1349-7006.1997.tb00423.x","volume":"88","author":"T Hasebe","year":"1997","unstructured":"Hasebe T, Tsuda H, Tsubono Y, Imoto S, Mukai K. Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within 3\u00a0years after the initial operation. Jpn J Cancer Res. 1997;88(6):590\u20139.","journal-title":"Jpn J Cancer Res."},{"key":"2955_CR7","volume-title":"World health organization classification of tumors of the breast","year":"2012","unstructured":"Lakhani SR, Ellis IO, Schnitee SJ, Tan PH, van de Vijver MJ, eds. World health organization classification of tumors of the breast. 4th ed. Lyon: IARC Press; 2012.","edition":"4"},{"issue":"5","key":"2955_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403\u201310.","journal-title":"Histopathology."},{"issue":"4","key":"2955_CR9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2559.2007.02761.x","volume":"51","author":"GG Eynden Van den","year":"2007","unstructured":"Van den Eynden GG, Colpaert CG, Couvelard A, et al. A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation. Histopathology. 2007;51(4):440\u201351.","journal-title":"Histopathology."},{"issue":"3","key":"2955_CR10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2559.2012.04234.x","volume":"61","author":"JY Tsang","year":"2012","unstructured":"Tsang JY, Lai MW, Wong KH, et al. alphaB-crystallin is a useful marker for triple negative and basal breast cancers. Histopathology. 2012; 61(3):378\u201386.","journal-title":"Histopathology."},{"issue":"8","key":"2955_CR11","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8):1736\u201347.","journal-title":"Ann Oncol."},{"issue":"16","key":"2955_CR12","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367\u201374.","journal-title":"Clin Cancer Res."},{"issue":"2","key":"2955_CR13","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/modpathol.3800528","volume":"19","author":"CA Livasy","year":"2006","unstructured":"Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol. 2006;19(2):264\u201371.","journal-title":"Mod Pathol."},{"issue":"1","key":"2955_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/modpathol.3800255","volume":"18","author":"TC Putti","year":"2005","unstructured":"Putti TC, El-Rehim DM, Rakha EA, et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod Pathol. 2005;18(1):26\u201335.","journal-title":"Mod Pathol."},{"issue":"10","key":"2955_CR15","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/modpathol.2010.123","volume":"23","author":"F Marginean","year":"2010","unstructured":"Marginean F, Rakha EA, Ho BC, Ellis IO, Lee AH. Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast. Mod Pathol. 2010;23(10):1357\u201363.","journal-title":"Mod Pathol."},{"issue":"5","key":"2955_CR16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jcp.45.5.416","volume":"45","author":"E Leonardi","year":"1992","unstructured":"Leonardi E, Girlando S, Serio G, et al. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. J Clin Pathol. 1992;45(5):416\u20139.","journal-title":"J Clin Pathol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2955-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-2955-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-2955-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:22:58Z","timestamp":1559632978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-2955-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,29]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["2955"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-2955-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,29]]}}}